Story
Axsome Therapeutics Options Market Braces for 8.6% Post-Earnings Move

The options market is signaling significant potential volatility for Axsome Therapeutics Inc. (NASDAQ:AXSM) surrounding its upcoming earnings announcement. Traders are pricing in a potential stock price move of 8.6% in either direction following the company's report, which is scheduled for release before the market opens on November 2.
This implied volatility figure is derived from the pricing of options contracts and serves as a market-based forecast of the stock's expected reaction to the new financial data. The data was compiled by Bloomberg.
Historical Volatility
A review of Axsome's past earnings reactions shows a tendency for the stock to be more volatile than the options market predicts. According to the data, the stock's actual price change surpassed the implied move in five of the last eight earnings announcements.
This pattern highlights the potential for significant surprises. For instance:
Ad- On May 4, the stock surged 20.3%, easily exceeding the 14.1% move priced in by options.
- On November 12, 2024, the stock jumped 14.0% against a much smaller implied move of just 3.4%.
Context for Investors
While the stock has a history of outsized reactions, there have also been periods of relative calm. On August 10, the stock moved only 1.3% when options had implied a 7.0% swing.
For investors, the 8.6% implied move serves as a key benchmark. The actual price action on November 2 will be measured against this expectation, and the company's history of significant volatility makes its earnings report a closely watched event.
Read next
More on Stocks
Telesat Stock Jumps as CIBC Highlights Undervalued Lightspeed LEO Asset
Shares in the satellite operator gained after CIBC initiated coverage with an 'Outperformer' rating, arguing the market is overlooking the value of its Lightspeed LEO constellation.

Goldman Sachs: AI Infrastructure Boom to Fuel Temporary Inflationary Pressures
The rapid buildout of artificial intelligence infrastructure will add temporary inflationary pressures to developed economies, with the U.S. expected to see a more pronounced impact, according to a new analysis from Goldman Sachs.

Life Time Group Stock Surges After Bullish Barclays Initiation
Shares of the fitness operator jumped after Barclays began coverage with an 'Overweight' rating and a $51 price target, citing the company's affluent customer base as a defense against a consumer spending slowdown.

Nutanix Stock Climbs as Guggenheim Initiates 'Buy' Rating on VMware Market Share Gains
Shares of Nutanix (NTNX) rose after Guggenheim initiated coverage with a 'Buy' rating and a $100 price target, citing the company's potential to capture customers migrating from rival VMware.